About the Authors

Aneesh Thakur

Roles Data curation, Formal analysis, Investigation, Writing – original draft

Current address: Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Affiliation Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Kgs. Lyngby, Denmark

Athina Andrea

Roles Data curation, Formal analysis, Methodology

Current address: Department of Science and Environment, Roskilde University, Roskilde, Denmark

Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark

Heidi Mikkelsen

Roles Data curation, Methodology

Current address: Analytical Development, ALK-Abelló, Hoersholm, Denmark

Affiliation Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Kgs. Lyngby, Denmark

Joshua S. Woodworth

Roles Formal analysis, Supervision

Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark

Peter Andersen

Roles Conceptualization, Funding acquisition

Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark

Gregers Jungersen

Roles Data curation, Funding acquisition, Project administration, Supervision

caa@ssi.dk (CA); grju@dtu.dk (GJ)

Current address: DTU Bioengineering, Technical University of Denmark, Kgs. Lyngby, Denmark

Affiliation Section for Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark, Kgs. Lyngby, Denmark

Claus Aagaard

Roles Conceptualization, Project administration, Supervision, Writing – original draft

caa@ssi.dk (CA); grju@dtu.dk (GJ)

Affiliation Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark

Competing Interests

The authors have read the journal’s policy and the authors of this manuscript have the following competing interests: J.W, P.A., and C.A. are employed by Statens Serum lnstitut, a non-profit government research facility of which the CAF adjuvants are proprietary products. The authors declare the following patents/patent applications relating to material pertinent to this article: The use of monomycolyl glycerol (MMG) as an adjuvant (WO 2009/003474) and Adjuvant combinations of liposomes mycobacterial lipids for immunization compositions and vaccines (WO 2005/004911). There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.